Guerrero Ramiro 4
4 · MAIA Biotechnology, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Guerrero Ramiro
Director
Transactions
- Purchase
Common Stock
2025-03-03$1.50/sh+33,333$50,000→ 568,218 total - Purchase
Warrants
2025-03-03$1.85/sh+33,333$61,666→ 33,333 totalExercise: $1.85From: 2026-03-03Exp: 2031-03-03→ Common Stock (33,333 underlying)
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on March 3, 2025.
- [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on March 3, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.